NCT07584577 Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer
| NCT ID | NCT07584577 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Esophageal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 670 participants |
| Start Date | 2026-11-01 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 670 participants in total. It began in 2026-11-01 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.
Eligibility Criteria
Inclusion Criteria: * Patient undergoing surgery for esophageal cancer * Malnourished patient at the time of management * Receiving neoadjuvant treatment Exclusion Criteria: * Patient not malnourished at the time of management * Patient who did not receive neoadjuvant treatment
Contact & Investigator
Caroline GRONNIER, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT07584577 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07584577 currently recruiting?
Yes, NCT07584577 is actively recruiting participants. Contact the research team at caroline.gronnier@chu-bordeaux.fr for enrollment information.
Where is the NCT07584577 trial being conducted?
This trial is being conducted at Pessac, France.
Who is sponsoring the NCT07584577 clinical trial?
NCT07584577 is sponsored by University Hospital, Bordeaux. The principal investigator is Caroline GRONNIER, MD, PhD at University Hospital, Bordeaux. The trial plans to enroll 670 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.